P115 Inhalable drug formulations for Idiopathic Pulmonary Fiborsis

Autor:	Esko I. Kauppinen, Amanda Attobrah, Katri Koli, Marjukka Myllärniemi, Ville Vartiainen, Janne Raula
Rok vydání:	2016
Předmět:	Drug medicine.medical_specialty media_common.quotation_subject Pharmacology Gastroenterology Drug formulations 03 medical and health sciences chemistry.chemical_compound Idiopathic pulmonary fibrosis 0302 clinical medicine Internal medicine medicine 030212 general & internal medicine media_common business.industry Tilorone General Medicine Pirfenidone respiratory system medicine.disease respiratory tract diseases 3. Good health Clinical Practice chemistry Lung disease Nintedanib business medicine.drug
Zdroj:	QJM: An International Journal of Medicine.
ISSN:	1460-2393
Popis:	Idiopathic pulmonary fibrosis (IPF) is a severe progressive fibrotic lung disease. During the past few years two orally administered drug candidates (pirfenidone and nintedanib) for slowing the progression of IPF were approved for clinical practice. Our research group discovered a potential antifibrotic drug, tilorone, using a high throughput screening and …
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::80a82aa1ce00662d3a27e10859dc5e89 https://doi.org/10.1093/qjmed/hcw120.016 Zobrazit plný text záznamu